Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
€ 0.78 2.72%

Quartalsbericht 2024-Q2
hinzugefügt 06.08.2024

report update icon

Sangamo Therapeutics Kennzahlen 2011-2024 | SGMO

Kennzahlen Jährlich Sangamo Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.5 -0.6 -6.1 -15.2 -8.5 -16.4 -30.0 -3.5 -10.4 -32.4 -41.9 -22.6 -4.7

P/S

0.8 1.1 9.8 15.5 7.9 13.3 44.7 12.9 10.7 18.7 46.2 23.2 16.2

EPS

-1.5 -1.2 -1.2 -0.9 -0.8 -0.7 -0.7 -1.0 -0.6 -0.4 -0.5 -0.4 -0.7

EV (Enterprise Value)

175 M 289 M 1.25 B 2.15 B 934 M 1.21 B 1.68 B 250 M 377 M 888 M 1.12 B 499 M 157 M

EBITDA per Share

-1.48 -1.23 -1.2 -0.864 -0.852 -0.772 -0.703 -1.01 -0.658 -0.388 -0.466 -0.408 -0.696

EV/EBITDA

-6.8 -14.7 -7.6 -13.1 -28.9 -3.2 -7.7 -32.7 -42.3 -22.4 -4.3

PEG

-0.04 -0.05 -1.02 0.56 0.4 16.75 -0.96 0.05 0.21 -1.73 2.93 -0.55 0.16

P/B

1.7 0.4 2.9 3.7 1.9 3.1 8.7 1.8 2.2 4.1 9.2 7.8 2.1

P/CF

-0.6 -0.5 -4.6 11.8 -4.9 -190.0 220.2 -3.8 -11.7 -136.2 -56.0 -57.1 -6.3

ROE %

-311.06 -65.19 -47.50 -24.28 -22.01 -18.64 -29.04 -52.61 -21.15 -12.78 -21.87 -34.31 -44.61

ROA %

-155.96 -34.18 -24.70 -12.89 -14.93 -11.57 -19.03 -45.38 -18.74 -10.86 -18.90 -26.98 -40.93

ROCE %

-330.58 -68.24 -48.85 -16.30 -18.53 -15.07 -23.30 -50.18 -23.77 -11.94 -20.39 -30.10 -44.70

Current Ratio

2.0 2.1 2.1 4.6 5.8 5.2 5.5 11.3 10.6 9.1 9.6 7.8 11.9

DSO

4.8 15.9 18.5 19.3 134.0 21.8 35.8 97.8 26.1 85.9 52.8 72.8 44.2

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

4.8 15.9 18.5 - - - - - - - - - -

Finanzkreislauf

4.8 15.9 18.5 - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Sangamo Therapeutics

2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.18 -0.59 -0.66 0.13 - -0.34 -0.29 -0.3 - -0.33 -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -0.18 -0.13 -0.17 -0.23 -0.15 -0.15 -0.17 -0.23 -0.14 -0.27 -0.38 -0.23 -0.2 -0.13 -0.17 -0.08 -0.06 -0.11 -0.1 -0.12 -0.13 -0.11 -0.1 -0.13 -0.07 -0.11 -0.11 -0.14 -0.12 -0.18 -0.2 -0.21

EBITDA per Share

- - - 0.13 - -0.29 -0.31 -0.29 - -0.29 -0.34 -0.31 - - -0.25 -0.37 - -0.23 -0.28 -0.42 - -0.14 -0.18 -0.24 - -0.14 -0.17 -0.23 - -0.26 -0.37 -0.23 - -0.17 -0.17 -0.09 - -0.11 -0.1 -0.12 - -0.1 -0.1 -0.13 - -0.1 -0.1 -0.14 - -0.17 -0.19 -0.18

ROE %

-272.42 -137.11 -77.10 -41.65 -43.90 -55.65 -50.20 -47.23 -32.10 -40.25 -28.82 -25.44 -24.28 -15.08 -21.08 -20.87 -22.01 -28.15 -25.34 -22.88 -18.64 -20.52 -23.59 -25.70 -29.04 -29.14 -36.49 -49.36 -52.61 -52.83 -43.71 -30.50 -21.15 -15.96 -14.81 -11.88 -12.78 -17.39 -18.78 -19.88 -21.87 -20.54 -24.42 -28.76 -34.31 -36.88 -39.88 -43.86 -44.61 -11.92 -12.80 -11.95

ROA %

-116.68 -86.79 -48.33 -19.82 -22.39 -28.57 -19.07 -24.72 -17.06 -21.38 -15.37 -13.56 -12.89 -7.85 -11.97 -12.89 -14.93 -18.81 -16.70 -14.77 -11.57 -12.98 -15.11 -16.65 -19.03 -20.56 -28.26 -40.74 -45.38 -45.74 -37.98 -26.73 -18.74 -14.06 -12.91 -10.20 -10.86 -14.87 -16.13 -17.13 -18.90 -17.34 -19.99 -23.06 -26.98 -30.04 -33.97 -38.77 -40.93 -10.94 -11.75 -10.97

ROCE %

-282.92 -144.14 -83.03 -44.51 -45.66 -57.58 -51.76 -48.32 -32.71 -33.45 -22.26 -18.94 -17.29 -24.05 -30.07 -30.20 -24.66 -29.09 -26.76 -24.23 -15.38 -22.32 -24.83 -26.40 -22.67 -36.77 -43.94 -56.85 -46.06 -52.65 -45.14 -31.81 -16.20 -19.91 -17.02 -14.05 -10.80 -15.86 -17.21 -18.30 -15.23 -24.17 -28.05 -32.41 -29.01 -40.96 -43.97 -47.95 -36.76 -11.95 -12.83 -11.98

Current Ratio

1.3 2.6 3.6 4.2 2.1 2.1 - 2.0 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 3.1 3.1 3.1 3.1 2.6 2.6 2.6 2.6 2.9 2.9 2.9 2.9 7.3 7.3 7.3 7.3 8.8 8.8 8.8 8.8 6.7 6.7 6.7 6.7 7.4 7.4 7.4 7.4 4.7 4.7 4.7 4.7 12.1 12.1 12.1 12.1

DSO

221.6 18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

221.6 18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

Finanzkreislauf

221.6 18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

Alle Zahlen in USD-Währung